You have access
Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
JUN YAMAMOTO, TAKUYA MURATA, NORIHIKO SUGISAWA, TAKASHI HIGUCHI, YOSHIHIKO TASHIRO, HIROTO NISHINO, SACHIKO INUBUSHI, YU SUN, HYEIN LIM, KENTARO MIYAKE, KOICHIRO SHIMOYA, TSUNEHISA NOMURA, JUNICHI KUREBAYASHI, HIROKAZU TANINO, CHIHIRO HOZUMI, MICHAEL BOUVET, SHREE RAM SINGH, ITARU ENDO and ROBERT M. HOFFMAN
Anticancer Research May 2020, 40 (5) 2475-2479; DOI: https://doi.org/10.21873/anticanres.14217
